HCA Healthcare, Inc. (HCA)
NYSE: HCA · Real-Time Price · USD
431.92
-13.85 (-3.11%)
At close: Apr 28, 2026, 4:00 PM EDT
434.90
+2.98 (0.69%)
After-hours: Apr 28, 2026, 7:59 PM EDT

Company Description

HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States.

The company owns, manages, and operates hospitals, ASCs, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, as well as rehabilitation and physical therapy centers, physician practices, home health agencies, hospices, outpatient physical therapy providers, home and community-based services providers, and various other facilities.

Its general and acute care hospitals offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic services, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.

HCA Healthcare, Inc.
HCA Healthcare logo
Country United States
Founded 1968
Industry Medical Care Facilities
Sector Healthcare
Employees 320,000
CEO Samuel Hazen

Contact Details

Address:
One Park Plaza
Nashville, Tennessee 37203
United States
Phone 615 344 9551
Website hcahealthcare.com

Stock Details

Ticker Symbol HCA
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000860730
CUSIP Number 40412C101
ISIN Number US40412C1018
Employer ID 27-3865930
SIC Code 8062

Key Executives

Name Position
Samuel N. Hazen Chief Executive Officer and Director
Michael A. Marks Chief Financial Officer and Executive Vice President
Jon Mack Foster Executive Vice President and Chief Operating Officer
Michael R. McAlevey Executive Vice President and Chief Legal and Administrative Officer
Dr. Michael S. Cuffe M.B.A., M.D. Executive Vice President and Chief Clinical Officer
Dr. Thomas F. Frist Jr., M.D. Founder and Chairman Emeritus
Christopher F. Wyatt Senior Vice President, Principal Accounting Officer and Controller
Chad J. Wasserman Senior Vice President and Chief Information Officer
Frank George Morgan C.F.A. Vice President of Investor Relations
Wendy Warren Senior Vice President and Chief Ethics and Compliance Officer

Latest SEC Filings

Date Type Title
Apr 28, 2026 8-K Current Report
Apr 28, 2026 FWP Free Writing Prospectus
Apr 27, 2026 8-K Current Report
Apr 27, 2026 424B3 Prospectus
Apr 27, 2026 S-3ASR Automatic shelf registration statement of securities of well-known seasoned issuers
Apr 24, 2026 8-K Current Report
Mar 27, 2026 SCHEDULE 13G/A Filing
Mar 13, 2026 ARS Filing
Mar 13, 2026 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Mar 13, 2026 DEF 14A Other definitive proxy statements